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Model-Based Closed-Loop Testing of Implantable Pacemakers
Abstract
The increasing complexity of software in implantable medical devices such as cardiac pacemakers and
defibrillators accounts for over 40% of device recalls. Testing remains the principal means of verification in the
medical device certification regime. Traditional software test generation techniques, where the tests are
generated independently of the operational environment, are not effective as the device must be tested within
the context of the patient's condition and the current state of the heart. It is necessary for the testing system to
observe the system state and conditionally generate the next input to advance the purpose of the test. To this
effect, a set of general and patient condition-specific temporal requirements is specified for the closed-loop
heart and pacemaker system. Based on these requirements, we describe a closed-loop testing environment
between a timed automata-based heart model and a pacemaker. This allows for interactive and physiologically
relevant model-based test generation for basic pacemaker device operations such as maintaining the heart rate
and atrial-ventricle synchrony. We also demonstrate the flexibility and efficacy of the testing environment for
more complex common timing anomalies such as reentry circuits, pacemaker mode switch operation and
pacemaker-mediated tachycardia. This system is a step toward a testing approach for medical cyber-physical
systems with the patient-in-the-loop.
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Abstract—The increasing complexity of software in im-
plantable medical devices such as cardiac pacemakers and
defibrillators accounts for over 40% of device recalls. Testing
remains the principal means of verification in the medical
device certification regime. Traditional software test generation
techniques, where the tests are generated independently of
the operational environment, are not effective as the device
must be tested within the context of the patient’s condition
and the current state of the heart. It is necessary for the
testing system to observe the system state and conditionally
generate the next input to advance the purpose of the test.
To this effect, a set of general and patient condition-specific
temporal requirements is specified for the closed-loop heart and
pacemaker system. Based on these requirements, we describe
a closed-loop testing environment between a timed automata-
based heart model and pacemaker. This allows for interactive
and physiologically relevant model-based test generation for
basic pacemaker device operations such as maintaining the
heart rate and atrial-ventricle synchrony. We also demonstrate
the flexibility and efficacy of the testing environment for more
complex common timing anomalies such as reentry circuits,
pacemaker mode switch operation and pacemaker-mediated
tachycardia. This system is a step toward a testing approach
for medical cyber-physical systems with the patient-in-the-loop.
I. INTRODUCTION
Safety recalls of pacemakers and implantable cardioverter
defibrillators due to firmware problems between 1990 and
2000 affected over 200,000 devices. This encompasses 41%
of the devices recalled [1]. An estimated 1.3 million device
checks and analyses and 36,187 device replacements resulted
from the advisories at a cost of approximately $870 million.
In 1996, 10% of medical devices recalls were caused by
software-related issues. In June of 2006, software errors in
medical devices made up 21% of recalls. During the first half
of 2010, the Food and Drug Administration (FDA) issued 23
recalls of defective devices, all of which are categorized as
Class I, meaning there is “reasonable probability that use of
these products will cause serious adverse health consequences
or death.” At least six of the recalls were likely caused by
software defects [2], [3].
The FDA currently does not request or review the medical
device software during pre-market submission. While no
specific requirements or software verification standards are
issued, a set of general guidelines for software evaluation are
recommended [4], [5], [6]. The responsibility to demonstrate
the safety and efficacy of the device software is solely on the
manufacturer. This is currently satisfied by the documentation
of code inspections, static analysis, module-level testing and
integration testing and their purpose is to establish “rea-
sonable assurance of safety and effectiveness”. These tests
however fail to check for the correctness of the software and
are largely open-loop tests that do not consider the context
of the patient. Software is reviewed by the FDA only in the
incident of a device recall. Software-related recalls are often
issued in the form of Safety Alerts by the Food and Drug
Administration (FDA) such as “Safety alert - Pacemaker may
revert to VVI mode at 70 beats/min if programmed to one of
several specific ventricular pulse widths”[2].
An effective software verification methodology is therefore
needed for the risk analysis and certification of medical
device software during the pre-market submission phase.
Testing for medical device software currently is ad hoc,
error prone, and very expensive. Traditional methods of
testing do not suffice as the test generation cannot be done
independently of the current state of the patient and organ.
As the testing environment (i.e. patient condition) is not
entirely under the control of the tester, the problem changes
significantly as a degree of nondeterminism is introduced
in the process. Implantable medical devices are a primary
example of Medical Cyber-Physical Systems where the safety
and efficacy of the device and device software must be
evaluated within a closed-loop context of the patient. The key
challenge is in the generation of physiologically relevant tests
such that the device does not provide inappropriate therapy
and does not adversely affect the safety of the patient. In
addition, test generation must be interactive and adaptive such
that the previous test stimulus affects the current state of the
patient. The test generator must consider the current state
when generating the next input in a way that advances the
purpose of the test. The problem, therefore, becomes one of
controller synthesis and cannot be addressed by an off-the-
shelf model checker [7].
The focus of this effort is three-fold: (a) We provide
a set of general and patient condition-specific pacemaker
software requirements to ensure the safety of the patient,
(b) We developed a timed automata-based heart model and
pacemaker device model for interactive and clinically relevant
test generation, and (c) We test the closed-loop system over
a variety of basic operation tests where the heart rate must
be maintained and the atrial-ventricle synchrony must be
maintained. Furthermore, we present a set of complex, but
common, cases such as supraventricular tachycardia due to
timing derangements caused by reentry circuits, pacemaker
mode-switch operation and pacemaker mediated tachycardia
condition. With this approach of model-based testing, an
executable functional model of the pacemaker is created at
an early stage in the development process. The focus of our
safety analysis is primarily on the timing behavior of the
closed-loop system as heart is the most important natural
real-time system. The timing of the intrinsic or induced
pacing directly affects the hemodynamics of the heart and
is a primary function of the stroke volume.
A. Model-based Medical Device Testing
Software embedded in a pacemaker or implantable defib-
rillator may have more than 80,000 lines of code [8]. There
is currently no software testing standard for implantable
medical devices. Testing is the observation of a program in
execution under controlled conditions. The outcome of a test
is compared with an oracle to determine the appropriate-
ness or correctness of the therapy. While formal methods
of verification is needed for medical device software [9],
[10], [11], testing continues to be required because it can
expose different kinds of problems (e.g., compiler bugs), can
examine the program in its system context, and increases the
diversity of evidence available. We do not have access to
the source code and black-box testing limits the scope of
evaluation. It is therefore necessary to develop a framework
for model-based testing wherein the device itself, or a model
of the device, is tested in closed-loop with the model of
the patient or the organ of concern. The key challenge with
model-based testing is having a good test generator. In the
case for implantable medical devices, the challenges for
software testing and test generation are manyfold:
1. Testing must be Physiologically-Relevant
Testing cannot be expected to catch every error in the
program and it is impossible to evaluate every execution path.
Many software errors, like unintended restarts or incorrect
measurements, do not surface until after the devices are
approved and in use. It is therefore necessary to provide
the appropriate kind and level of abstraction of the patient
and device model for testing. In our previous work [12], we
developed a Virtual Heart Model (VHM) and dual chamber
DDD pacemaker model in Simulink for medical device
validation. The VHM is an electrophysiological model of the
heart and models the timing and electrical conduction of the
heart with both intrinsic and artificial pacing signals. In this
paper, we use the VHM for closed-loop testing of pacemaker
functionality for baseline and common complex test cases.
2. Non-deterministic factors in Testing
Traditional software testing is an open loop exercise to test
for generic bugs and incorrect execution given a set of struc-
tural coverage criteria. This lends itself to Automated Test
Generation by methods such as theorem proving, constraint
logic programming and symbolic execution, model check-
ing, using an event-flow model and using a Markov chains
model [7]. The test-generation problem becomes significantly
more complex and difficult when the program under test is
non-deterministic or when the functionality of the program
is a function of not only the computing and communication
components but the operational environment. In the case of an
implantable medical device such as an artificial pacemaker,
the closed-loop system of the heart and the device must be
tested as a whole, within the context of the patient’s condition
(see Fig. 1).
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Figure 1. Closed-loop model of the heart and pacemaker in the context of
the patient condition. Our focus is on the inner loop of the heart model and
the pacemaker model.
3. Interactive and Adaptive Testing
The primary approach to system-level testing of medical
devices is unit testing using a playback of pre-recorded
electrogram and electrocardiogram signals [13], [14]. This
tests if the input signal triggers a particular response by the
pacemaker but has no means to evaluate if the response
was appropriate for the patient condition. Furthermore, this
approach of “tape testing” is unable to check for safety
violations due to inappropriate stimulus by the pacemaker.
Pacemaker Mediated Tachycardia (PMT), a condition that
is described later in this paper, is a strong example of why
we need an interactive and adaptive test generation systems
such as the VHM. PMT is a condition where the pacemaker
inappropriately drives the intrinsic heart-rate toward the
upper rate limit. With a tape test, PMT would not occur
and the response of the pacemaker could be classified as
appropriate therapy.
The focus of this work is on the development of a system
and methods for integration and system-level testing for
implantable cardiac pacemakers. To address this, we specify
a set of general and condition-specific requirements for the
closed-loop system. We evaluate this by constructing a set
of monitors to test for timing and safety conditions for each
case.
B.. Organization
The rest of this paper is organized as follows. In Section
II, we describe the construction and interfaces of a timed
automata based heart model developed in Simulink. Section
III presents the model of a pacemaker which interfaces with
the heart model to generate a set of closed-loop physiological
tests cases described in Section IV. Sections V-A and VI
present the test generation and testing of the closed-loop
system with a set of monitors. We then conclude the paper
with a set of future directions toward more rigorous and
formal medical system verification.
II. HEART MODEL
We developed a timed automata-based Virtual Heart Model
(VHM) to model the timing and electrical conduction prop-
erties of the heart. The model, developed in Simulink, was
constructed to serve as an adaptive test generator for a variety
of heart conditions. The VHM responds to both intrinsic
(natural) pacing and external (artificial) pacing stimulus and
is capable of generating tests for the following common
conditions:
1) Normal Sinus Rhythm and Sinus Bradycardia
2) Wenckebach Second-degree Heart Block
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Figure 2. (a) Action potential recorded from ventricular tissue. The dashed lines show how action potential morphology changes when a
stimulus is applied early to the tissue and how the corresponding timer values change.(b) Node automaton. (c) Path automaton
3) Atrial Flutter
4) Pacemaker Mediated Tachycardia
In our previous work [12], several arrhythmias were vali-
dated by an electrophysiologist to be clinically relevant. For
completeness, we briefly describe the design of the VHM
using timed automata. For more details, refer to [12].
A.. Timing Model of the Virtual Heart Model
Modeling individual cells in order to obtain a view of
the entire heart is processor heavy and contains extraneous
information for purposes of device testing. Instead, the VHM
utilizes the timing properties of the heart to obtain a macro-
level view by lumping cells into node and path automaton.
The heart can be represented as a conduction network
(Fig. 3(a)), because a section of activated heart tissue can only
activate its neighboring tissue. For example, an a conduction
path from tissue A to tissue B, a stimulus cannot reach B if
A is in refractory (i.e. the cells are discharged), even if B is
at rest. We can use this idea to model a section of tissue
as two node automata connected by one path automaton.
The refractory properties of the component are represented
by the nodes and the conduction properties between the
nodes are modeled by the path. We can represent different
structures of the heart using nodes and paths with different
parameters. The basic state transitions of the node automaton
and the path automaton are shown in Fig. 2(b) and Fig. 2(c).
In node automaton, the refractoriness is modeled as the
Effective Refractory Period (ERP) when no conduction can
occur, Relative Refractory Period (RRP) when attenuated
conduction may occur and Rest states when the cell is
fully excitable. In path automaton, the tissue conduction
(a) (b)
Figure 3. (a) The basic electrical conduction system of the heart.
(b) Corresponding setup of nodes (dots), paths (lines) and probes
(shapes) in our heart model.
properties are modeled as no conduction (Idle), antegrade
or forward conduction (Ante), retrograde or backward con-
duction (Retro), conduction in both directions (Double), and
conflict (Conflict) state. Each state has an internal timer
Tstate, and the paths have conduction velocity Vstate. The
default refractory and conduction parameters are tuned in
relation to the true refractory periods measured in clinical
electrophysiology studies[15]. These allow us to produce
clinically-relevant results [12].
It has been studied in [16] and [17] that the action
potential duration is dependent on the timing of stimulus
(see Fig. 2(a)). We use an exponential approximation of the
trend to create similar behavior. In addition, the portion of the
total refractory period that is unexcitable is dependent on the
amplitude of the stimuli [18]. For simplification, we assume
a fixed amplitude for all stimuli, which is the case in most
implantable devices. The state transitions of node automaton
and path automaton are shown below (all timer equations are
described in [12]:
1. Node automata state transitions
- When activation signal is received at a node
• In Rest state: go to ERP state, calculate the value of
timer Terp, reset the ERP timer, activate neighboring
paths and change the Tante or Tretro timers.
• In ERP state: calculate Terp, neighboring paths are not
activated.
• In RRP state: go to ERP state, activate neighboring
paths, calculate Terp, and change the conduction velocity
of neighboring paths.
- When no activation signal is received at node
• In Rest state: SA and AV nodes count down the Rest
timer, when the timer times out, activate itself, go to
ERP state, activate neighboring paths and change the
conduction speed of neighboring paths. Other nodes stay
in Rest state.
• In ERP state: count down ERP timer and go to RRP
state after the timer runs out.
• In RRP state: count down RRP timer and go to Rest
state after the timer runs out.
2. Path automata state transitions: The path automata
is initially Idle until either of the nodes it connects to is
activated (Act 1 or Act 2). The path starts the antegrade
or retrograde conduction timer according to which node is
activated. After Tante or Tretro times out, the path activates
the node at the opposite end. Because this node activates
all paths it is connected to, the path where the activation
originated goes to Conflict state to prevent back conduction.
If a path is already in antegrade conduction when a second
activation signal enters from the opposite end, the path enters
the Double state. Both Tante and Tretro count down until the
timers correspond to the same location in space and the path
goes to the Conflict state then back to Rest state.
B.. Functional and Formal VHM interface
Our platform provides two interfaces, a formal signal for
interfacing with medical device software and a functional
electrogram for real device implementation. We introduce
probes into the model which mimic sensing from electrodes
in catheters or pacemaker leads. These probes generate syn-
thetic unipolar electrograms by multiplying activations on
neighboring paths by a distance-dependent Gaussian factor
and summing them together. The bipolar electrograms are
calculated as the differences between two unipolar signals.
The bipolar formal signal is generated using an AND
operation between the two unipolar formal signals. Varying
the location of the probe pair and the conduction delay of
the path can causes changes in electrogram morphology. The
formal signal is useful for interacting with medical device
software running at a lower frequency than the VHM.
C.. Simulink Implementation of the VHM
The general automata and probe set used in our simulations
is shown in Fig. 3(b) with 32 nodes and 33 paths. The
probes are placed in specific areas to capture key activation
timing intervals in the heart. A simulation GUI developed in
Simulink and the automata network is superimposed on the
heart anatomy. The length of paths are measured in pixels
to provide a relative length relationship between different
heart structures. Users can track the updated values of timers
on the right side tables. Users can view electrograms and
deliver programmed pacing in real-time. Simulink was chosen
because both the functional and formal models could be
developed from a common kernel. The VHM interfaces with
the pacemaker model, which is described next.
III. PACEMAKER MODEL
A.. Pacemaker model
As no pacemaker software or model is available, we
developed a pacemaker model to mimic the behavior of a real
pacemaker based on pacemaker timing cycles. The 5 basic
timing cycles for a dual-chamber DDD mode pacemaker
are shown in Fig. 4 [19]. Since these timing cycles are
mostly independent of each other, we model them as 5
independent modules running in parallel. This also enable
us to use the same model for different pacemaker modes by
disabling the corresponding module. Pacemaker models for
AAI and DDD modes were implemented and tested. AAI
mode is a single chamber mode which senses and paces
in the atrium. Its function is to keep the atrial rate above
a certain threshold. DDD mode is a dual chamber mode
which senses and paces in both atrium and ventricle. Besides
maintaining both atrial and ventricular rate, DDD mode also
includes A-V synchrony, which can optimize hemodynamics.
The description and design of the 5 modules are introduced
below:
1. Lowest Rate Interval (LRI): LRI is the most basic
timing cycle for pacemaker. Its function is to maintain the
heart rate above a certain level. It can be modeled as a timer
with some logic. The timer is started and reset by ventricular
event. If there is no ventricular event is sensed before the
timer runs out, the pacemaker will deliver ventricular pacing.
2. Atrio-Ventricular Interval (AVI): The function of the
AVI module is to keep A-V synchrony. The timer is started
by atrial events. If no ventricular event happens before the
timer runs out, the pacemaker will deliver ventricular pacing.
3. Three auxiliary modules: The post ventricular atrial
refractory period (PVARP) module is a blocking period which
is started by a ventricular event. During this period no atrial
sense event can be triggered. The ventricular refractory period
(VRP) module is a blocking interval which is started by
a ventricular event. During this period no ventricular sense
event can be triggered. These two modules are designed to
filter out noise so that only real events are sensed. The upper
rate interval (URI) component provides an upper bound for
ventricular pacing. AVI timer is extended and the ventricular
pacing is withheld to prevent the pacemaker from pacing the
ventricle too fast.
Besides the basic timing cycles, a simplified version of
Mode-switch operation was implemented. Wit Mode-swtich,
the pacemaker should switch from DDD to VDI mode if the
atrial rate is above certain threshold and switch from VDI
to DDD mode if the atrial rate drops below a certain level.
This function is to ensure the A-V synchrony function of
the pacemaker does not track abnormally fast atrial rates and
cause ventricular tachycardia. A timer is set to monitor the
interval between two consecutive atrial events. Any value
smaller than a specified threshold is considered as a fast
atrial beat. A counter tracks the number of fast atrial beats.
If there are certain number of consecutive fast atrial beats
the pacemaker will switch from DDD to VDI. During VDI
mode the pacemaker paces and senses the ventricle but still
keeps track of the interval between atrial beats. If a slow
atrial beats is detected, the pacemaker will switch from VDI
to DDD mode.
IV. PHYSIOLOGICAL CASE STUDIES
We simulated four common clinically-relevant heart con-
ditions using the closed-loop VHM and pacemaker model.
Based on these conditions we derived a set of safety and
efficacy requirements for the pacemaker (Section V-A). Fol-
lowing this, we applied monitors to the close-loop system to
Figure 4. DDD mode pacemaker timing cycles.
Figure 5. Electrograms of induced Wenckebach block in the heart model
with a beat interval of 420ms. The heart model displays lengthening in the
A-H interval and block in A-V node (1). Rows 5 and 6 show the increase
in the ERP and conduction delay of the A-V node.
evaluate if the requirements are satisfied (Section VI). This
section describes the electrophysiological details of each case
so that we may understand the clinical relevance prior to
testing. The detailed cases and detailed description can be
found in [12].
A. Maintain appropriate heart rate
Maintaining appropriate heart rate is essential for keeping
efficient blood flow throughout the body. Heart rate can
be classified into Normal Sinus Rhythm (NSR, i.e. normal
heart rate), Bradycardia (i.e. abnormally slow heart rate) and
Tachycardia (i.e. abnormally fast heart rate). The mechanism
of Sinus Bradycardia is when the SA node, which serves
as natural pacemaker, fails to generate a fast enough heart
rate to satisfy blood demand of the body. Sinus Bradycardia
is the most basic and common arrhythmia which requires
pacemaker therapy. The pacemaker can provide electrical
impulses at the appropriate time intervals to maintain the
heart rate above certain level. Pacemaker does not provide
Tachycardia therapy but it needs to prevent itself from
inducing the heart into the dangerous Tachycardia condition.
B. Maintain Atrioventricular Synchrony
Besides heart rate, atrioventricular (AV) synchrony is an
important property to be satisfied to maintain efficient hemo-
dynamics. AV heart block is a heart condition where the elec-
trical conduction between the atria and ventricles is delayed
or blocked. This is caused by the abnormal behavior of the
AV node. In this case, we introduce the Wenchebach-type AV
block, which features a progressively prolonged AV delay
that eventually results in dropped beats. Fig. 5 shows the
electrograms, the corresponding ERP period and conduction
delay of the AV node automata in a VHM simulation.
From the His Bundle Electrogram (HBE in the figure), we
observe the second stimulus which arrived at the AV node
Figure 6. Mechanism of reentry circuit
Slow pathway: retrograde
A-V conduction
Fast “pathway”: pacemaker
A-V synchrony
Figure 7. Illustration of the reentry circuit in Endless Loop Tachycardia
(marked as A in the figure) falls into the RRP period of the
AV node. Consequently, the ERP period and the conduction
delay of AV node are increased according to the timer equa-
tions referenced in Section II. After a series of stimuli, the
ERP period is longer than the interval between two stimuli.
This results in the blocking of the last stimulus at the AV
node, causing a dropped beat (marker 1 in the figure). In the
AV heart block situation, a dual chamber pacemaker should
be employed to maintain the AV synchrony by appropriately
pacing the atrium and ventricle in a coordinated manner.
C. Pacemaker Mediated Tachycardia
Pacemaker Mediated Tachycardia (PMT) is the circum-
stance where the pacemaker paces the heart at an inappro-
priately high rate. In the following two cases, we observe
the pacemaker can introduce complications that may lead to
unsafe heart conditions.
1) Endless Loop Tachycardia (ELT): is a situation where
the pacemaker and heart tissue form a “circuit”, which
is known as reentry circuit. Reentry circuit is one of the
most common reason for Tachy-arrhythmia. Its mechanism is
based on timing anomalies caused by additional (accessory)
conduction pathways within the heart. In this situation the
“additional pathway” is the pacemaker AV synchrony func-
tion. Fig. 6 illustrates the mechanism of a reentry circuit.
A reentry circuit is formed by two conduction pathways.
One has a short conduction delay but with a long blocking pe-
riod (ERP), and the other has long conduction delay but with
a short blocking period. During normal conduction (Fig. 6-0),
stimulus propagates though both pathways. Since the signal
through the fast pathway arrives at the circuit exit earlier, it
will conflict with the signal through the slow pathway and
they cancel each other. In this case, the circuit is equivalent
to a single fast pathway. However, if another stimulus enters
into the circuit shortly after the previous one (Fig. 6-1), it
will be blocked in the fast pathway and go through the slow
pathway as the fast pathway has a longer blocking period.
When this stimulus arrives the circuit exit (Fig. 6-2), the
blocking period of the fast pathway whould have ended and
the stimulus propagates retrogradely (i.e. in reverse direction
to normal conduction) through the fast pathway. The stimulus
will then loop around the circuit and send stimuli to both the
circuit’s entry and exit (Fig. 6-3). Since the timing interval
of circling around the circuit is shorter than the intrinsic
heart rate, the circuit will become the dominating source of
Figure 8. The first ventricle sense (VS) is a Premature Ventricular
Contraction (PVC). It propagates retrogradely to the atrium and triggers
atrial sense (AS). The AS-VP interval is equal to the AVI timer value of
the pacemaker. The VP-AS intervals are equal to the first VS-AS interval,
indicating all VPs are also going retrogradely to the atrium. The resulting
heart rate is around 150bpm.
activation for the heart and cause Tachycardia. This condition
must be detected by the pacemaker and must inhabit pacing
that may lead to assisting the Tachycardia condition.
Fig. 7 shows the mechanism of ELT where natural con-
duction pathway serves as the slow pathway of the circuit
and the A-V synchrony function of the pacemaker serves
as the fast “pathway”. A Premature Ventricle Contraction
(PVC) can trigger retrograde conduction through the slow
pathway and triggers atrial sense event in the pacemaker.
The pacemaker will then pace the ventricle after the AVI
timer runs out, triggering another retrograde conduction and
causing reentrant tachycardia. The VHM’s simulation result
is shown in Fig. 8.
2) Atrial Flutter and Pacemaker Mode-Switch function:
Supraventricular Tachycardia (SVT) is the most common
Tachy-arrhythmia and features a very fast atrial rate. SVT
itself is not fatal since a functioning AV node will filter out
some of the stimuli to the ventricle and the ventricular rate
remains relatively normal. However, complications may arise
if there exist other means, besides the AV node, to provide A-
V synchrony. This is likely in the form of additional pathways
or due to fast atrial “tracking” by a DDD dual chamber
pacemaker.
Atrial Flutter is one of the most common SVTs and is
caused by reentry circuits. In a large population group, there
exists a slow conduction pathway in the right atrium which
forms a reentry circuit along with the normal conduction
pathway. Fig. 9-a shows synthetic EGMs of an intermittent
Atrial flutter case without pacemaker. During Atrial flutter,
the atrial rate is around 240bpm but only around half of
them conduct to the ventricle so the ventricular rate is
around 100bpm. When the Atrial flutter terminates, the heart
condition changes to bradycardia.
With a dual chamber pacemaker in DDD mode implanted,
the heart rate and A-V synchrony are maintained during
Bradycardia. However, during Atrial flutter, the A-V syn-
chrony function of the pacemaker will pace the ventricle for
every sensed atrial event and lead to unsafe ventricular tachy-
cardia.(Fig. 9-b) During SVT-like Atrial Flutter, maintaining
an appropriate ventricular rate is much more important than
maintaining A-V synchrony. In order to prevent inappropriate
A-V synchrony, the pacemaker should be able to detect SVT
and disable the A-V synchrony function during SVT while
keep A-V synchrony during bradycardia and A-V block.
Figure 9. Simulation results for intermittent Supraventricular Tachycardia
A Mode-switch function has been introduced to switch to
single chamber mode (VDI) during SVT. Fig. 9-c shows the
simulation result for pacemaker with Mode-switch function
during SVT.
After detecting five consecutive fast atrial events, the
pacemaker switchs from DDD mode to VDI mode (first MS
marker in Fig. 9-c), which is a single chamber mode that
paces and senses only in the ventricle while monitoring the
interval between atrial events. After the SVT terminates, the
pacemaker detects a long coupling interval between atrial
events and switches back to DDD mode (second MS marker
in Fig. 9-c). With the Mode Switch function, the pacemaker
delivers appropriate therapy during different heart conditions.
A more detailed description can be found in [20].
V. CLOSED-LOOP REQUIREMENTS
In this section, we describe a set of requirements that are
imposed on the closed-loop system to guarantee the safety
and efficacy of the system. These requirements can not only
be used for testing methods proposed here, but also for
verification of the closed-loop system.
A. Patient condition
From a physiological point of view there are certain re-
quirements that the closed-loop system needs to satisfy. Some
properties are absolute and some of them are conditional.
For conditional properties, we specify heart states as patient
conditions (see Fig. 10). In the closed-loop system these heart
states are connected to the heart model parameters and won’t
be changed by the pacemaker therapy. This will allow us
to evaluate whether the pacemaker provides an appropriate
therapy for certain types of arrhythmias.
State Conditions Equivalence in VHM
NSR Intrinsic heart rate between 
60-120bpm
Trest_SA within [500 
1000]; 
Brady Intrinsic heart rate<60bpm Trest_SA>1000
Sinus 
Tachy
Intrinsic heart rate>120bpm Trest_SA<500
A-V 
Block
AV node ERP is long so that 
A-V conduction is slow or 
blocked
TERP_AV>400
SVT Atrial rate above 200 due to 
reentry circuit
Interval between two 
Activation_SA is shorter 
than 250ms && 
Trest_SA>600
Figure 10. Patient state and equivalence in VHM
B. General requirements
Fig. 11 shows several general requirements that a rhythm-
management implantable device should be able to satisfy,
as well as the corresponding VHM logic. The requirements
range from safety requirements to efficacy requirements and
each requirement is assigned a priority. The device should
always try to satisfy a higher priority requirement even if
a lower priority requirement may be violated. The highest
priority requirements have the smallest priority value.
The parameters of the close-loop system which are exposed
to the monitors are also specified. State [node name] and
Activation [node name] are the current state and activation
status of the node automata. Condition [heart state name]
is a boolean value for whether the heart state is true.
a p, v p, a s and v s are the pace and sense events of the
pacemaker.
1) No Ventricular pace should happen during ventricle re-
fractory (Priority 1): This requirement is the most important
safety requirement for implantable cardiac device. Pacing
Index General Requirements Correspondence in the close-loop system Priority
1
No ventricular pace should 
happen during ventricle 
refractory
If State_RVA=ERP, no v_p should 
happen 1
2
Each atrial and ventricular 
event should be sensed by 
the corresponding lead
Interval between two Activation_RVA
should between 500ms to 1000ms
2
3
Ventricular rate should be 
maintained between 60bpm 
and 120bpm 
If Condition_NSR=true, Interval 
between two 
Activation_RVA shouldn’t be larger 
than Trest_SA; 
If Condition_Brady=true,  Interval 
between two a_p should be equal to 
LRI timer of pacemaker
3
4
Without activity sensor, the 
pacemaker should not 
increase ventricular rate 
above it’s programmed LRI 
during Brady and above
intrinsic heart rate during 
NSR
If Activation_SA=true, a_s=true; 
If Activation_RVA=true, v_s=true; 4
5
If the intrinsic heart rate is 
below some threshold, After 
each atrial event there 
should be a ventricular event 
within some interval(1:1 
conduction)
If Interval between two 
Activation_SA is larger than 600, 
after each Activation_SA, there 
should be a Activation_RVA within 
[100, 150]
5
6
No activation conflict should 
happen within muscle tissue
musclepaths=path automata 1-10 in 
Fig 3(b); State_musclepaths should 
never be Double
6
Figure 11. General requirements for the close-loop system
during the ventricle refractory period creates derangements
in timing across the ventricle. This disturbs the normal
coordinated contraction of the ventricle and can lead to unsafe
ventricle fibrillation.
2) Each atrial and ventricular event should be sensed by
the corresponding lead (Priority 2): Sensed intrinsic heart
activation signals are essential inputs for the pacemaker. The
pacemaker should ensure that the actual heart activations are
accurately sensed and noise should be filtered.
3) Ventricular rate should be maintained between 60bpm
and 120bpm (Priority 3): Ventricular rate determines the
actual cardiac output. It is necessary for the pacemaker to
keep the ventricular rate above a certain level to ensure the
requisite cardiac output and below certain level to ensure
efficient pumping.
4) Without an activity sensor the pacemaker should not
increase the ventricular rate above its programmed LRI
during Bradycardia and above the intrinsic heart rate during
NSR (Priority 4): In some cases, the pacemaker may try to
pace the heart at inappropriate high rate (like the two PMT
cases in Section IV). The pacemaker should always give
intrinsic heart signal higher priority and increase the heart
rate only when it’s necessary.
5) If the intrinsic heart rate is below a certain threshold,
after each atrial event there should be a ventricular event
within a predefined interval (Priority 5): A 1:1 A-V conduc-
tion should be maintained and coordinated to ensure efficient
pumping. This is an efficacy requirements of the closed-loop
system.
6) No activation conflict should happen within muscle
tissue (Priority 6): Activation conflicts within the muscle
tissues disturbs the normal contraction pattern which might
compromise the efficacy of cardiac output. Consequently, in-
trinsic and artificially paced signal should ensure coordinated
contraction without conflicts across the muscle paths 12-16
(as shown in Fig. 3(a)).
C. Conditional requirements
Besides the general requirements, additional conditional
requirements are specified for specific patient condition
such as Normal Sinus Rhythm, Bradycardia, Heart Block,
Supraventricular tachycardia and Endless Loop Tachycardia.
These requirements are shown in Fig. 12 and cover common
critical patient conditions.
Condition Requirement given condition Correspondence in VHM
NSR=true && A-V 
block=false
No a_p and v_p should happen a_p=false; v_p=false
Brady=true && A-V 
block=false
no a_s and v_p should happen a_s=false; v_p=false
Brady=true && A-V 
block=true
no a_s and v_s should happen a_s=false; v_s=false
SVT=true && 
State_PM=DDD
Mode switch to VDI should happen 
within 5s 
PM_ModeSwitch=true 
within 5s && 
PM_NextState=VDI
SVT=false &&
State_PM=VDI
Mode switch to DDD should 
happen if the atrial rate is lower 
than 60bpm
if Interval between two 
Activation_SA is larger than 
1000, 
PM_ModeSwitch=true && 
PM_NextState=DDD
Figure 12. Conditional requirements for the close-loop system
VI. CLOSED-LOOP SYSTEM TESTING
Currently there does not exist a unified approach for
Simulink models verification. Therefore, we use a testing pro-
cedure similar to Instrumentation Based Verification (IBV)
[21]. In this procedure, monitors are designed and utilized to
check for any violation of the requirements. The proposed
approach uses coverage-based testing and, thus, it can be
used only in combination with tools for automatic test data
generation. Several such commercial (e.g., Reactis, Design
Verifier) and non-commercial (e.g. [22], [23]) tools exist.
However, to test case studies described in Section IV the
closed-loop system input test vectors are created based on
physiological requirements.
In this section, we describe design of the monitors used
for testing of the requirements presented in Section V-A, a
method used to generate input test cases, along with results
obtained with these test vectors.
A. Monitor Designs
For each requirement described in Section V-A, a monitor
is designed to generate an event when a violation of the
property occurs. Using Assertion block in Simulink we are
able to detect any violation of the imposed closed-loop
system requirement and capture the execution scenario (i.e,
simulation trace) which has led to the violation.
Design monitors utilized for the closed-loop system testing
are grouped into the following categories:
M1. Monitors for logical conditions: When a requirement can
be described using logical operations over system’s signals,
it is necessary to check whether at each time instance the
predefined combination of signals and/or (VHM and pace-
maker’s) states might occur. For example, the first condition
from Fig. 11 can be described as:
(StateRV A == ERP ) ∧ (¬Vpace).
M2. Single event monitor: A subset of the requirements can
be described as a combination of time dependencies between
consecutive appearances of a single event. For example, the
second requirement from Fig. 11 will be satisfied if time
durations between all consecutive RVA activation signals
belong to a region [0.5s, 1s]. A single event monitor shown in
Fig. 13 is utilized to detect any violations for this type of re-
quirements. Values for Tlow and Thigh are used to determine
the required time span between consecutive manifestations of
the same event.
M3. Monitors for timing dependencies between different
events: A subset of requirements imposes conditions that an
event E2 always appears only after an event E1. In addition,
the time duration between these two events has to be within
a predefined bound. For example, consider Requirement 5
from Fig. 11. It imposes a condition that the SA activation
signal is always followed by the RVA activation signal. In
TimeMonitor_SingleEvent
FailIdle
{MState=0;
Fail = 0;}
[~event&after(Thigh,sec)]
{MState = 2; Fail = 1;}
2
[event&(temporalCount (sec)<Tlow)]
{MState=2; Fail  =1;}
3
[event]
{MState = 1;}
1
Figure 13. A Single Event Monitor.
TimeMonitor
FailIdle
FirstEvent
{MState=0;
Fail = 0;}
[event2]{Fail=1;MState=2;}
2
[event2&(temporalCount (sec)>=Tlow)]
{MState=0;}
2
[event1&(~event2)]
{MState = 1;}
1
[~event2&after(Thigh,sec)]
{MState = 2; Fail = 1;}
1
[event2&(temporalCount (sec)<Tlow)]
{MState=2; Fail  =1;}
3
Figure 14. Design of a monitor used to check timing dependencies
between events.
addition, the RVA activation signal must not occur before
100ms have elapsed from the SA activation or later than
150ms after the SA activation signal (i.e., lower and upper
bound). The monitor used to check for violations for this
type of requirements is presented in Fig. 14 where the time
interval is described as [Tlow, Thigh].
M4. Combination monitors: In general, a requirement can
be described as a combination of the previously described
requirements (from M1-3). In this case, the aforementioned
monitors are composed to generate intermediate signal-
s/events. However, it is necessary to modify the monitors
presented in Fig. 13 and Fig. 14. These ‘modified’ monitors
have a similar structure as M1-M3 with a difference that
they do not contain the Fail state and all transitions to the
Fail state in the initial monitor designs are altered to become
transitions to the Idle state. These modifications enable a
continuous tracking of the intermediate properties that would
not be possible if the monitor gets blocked in the Fail state,
after the appropriate scenario occurs.
To illustrate this, consider a monitor in Fig. 15 used
to check the fifth requirement from Fig. 11. The monitor
combines a ‘modified’ Single Event Monitor. In this case, by
setting the monitor’s parameters Tlow = 0s and Thigh = 0.6s,
its output signal (i.e., TM SingleEvent.Fail) represents
the condition that the heart rate is below the predefined
threshold. In addition, a ‘modified’ monitor of type M3
with parameters Tlow = 0.1s and Thigh = 0.15s is used
to check time durations between SA and RVA activation
signals. Outputs of these ‘modified’ monitors (i.e., signals
TM SingleEvent.Fail and TM.Fail) are combined to
generate a logical signal whose occurrence represents a
violation of the tested property.
HR_below_threshold
1
TM_SingleEvent
event
MState
Fail
TM
event1
event2
MState
Fail
Logical
Operator1
NOT
Logical
Operator
AND
Data Type Conversion2
boolean
Data Type Conversion1
boolean
Data Type Conversion
boolean
Assertion
RVA_activation
2
SA_activation
1
Figure 15. An example of a combination monitor derived as a composition
of the basic monitors from Fig. 13 and Fig. 14.
Case 1 & 2: Maintaining heart rate and A-V synchrony
Requirements
NSR Brady
No AV block AV block No AV block AV block
No PM AAI PM DDD PM No PM AAI PM DDD PM No PM AAI PM DDD PM No PM AAI PM DDD PM
1: No v_p during 
refractory
N/A Check Check N/A Check Check N/A Check Check N/A Check Check
2: Events sensed N/A Check Check N/A Check Check N/A Check Check N/A Check Check
3: Maintain 
Ventricle rate
Check Check Check Violated Violated Check Violated Check Check Violated Violated Check
4: Rate increase 
when necessary
N/A Check Check N/A Check Check N/A Check Check N/A Check Check
5: A-V synchrony Check Check Check Violated Violated Check Check Check Check Violated Violated Check
6: No muscle tissue 
conflict
Check Check Check Check Check Check Check Check Check Check Check Check
NSR=true && 
A-V block=false
N/A Check Check N/A N/A N/A N/A N/A N/A N/A N/A N/A
Brady=true && 
A-V block=false
N/A N/A N/A N/A N/A N/A N/A Check Check N/A N/A N/A
Brady=true && 
A-V block=true
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A Check Check
Figure 16. Simulation results for Maintain heart rate and A-V synchrony
B. Generation of Test Vectors
To test the close-loop system we need to specify the inputs
for the heart model to cover certain physiologically relevant
heart conditions. We now specify inputs of the VHM for the
four cases discussed in section IV. In our test approach, the
inputs of the heart model are only those heart parameters
which can change over time. This property significantly
reduces the number of inputs and the model complexity.
1) Maintaining the heart rate: The heart rate is a function
of the blood demand of the body and is controlled by
the nervous system. The nervous system controls the heart
rate by changing the firing rate of the SA node. Failure to
increase the heart rate when needed leads to Bradycardia.
Correspondingly, we can alter the heart rate of the VHM by
changing the Trest timer value of the SA node automata.
In this base case, we model the heart rate variation of a
patient with intermittent Bradycardia. The range of Trest of
the SA node automata is confined to [600, 1500]ms so the
corresponding heart rate is between 40bpm and 100bpm. This
input sequence for SA node automata will also be used for
the latter cases.
2) Maintaining A-V synchrony: The nervous system con-
trols the A-V conduction delay/block by changing the ERP
timer of the AV node. Correspondingly, we mimic the be-
havior in VHM by changing the TERP timer value of AV
node automata. For simplicity, we only specify two distinct
values for the TERP timer value of AV node automata, which
correspond to the state “AV-block” and “No AV block”.
3) Endless Loop Tachycardia (ELT): In this case, we
are interested in how Pacemaker Mediated Tachycardia can
influence the requirements satisfaction. Here we use the same
input in Case 2 for the SA and AV node automata, and
introduce Premature Ventricle Contraction (PVC) to induce
Endless Loop Tachycardia. In this case, we set the RV node
automata to be active 200ms after the simulation begin.
4) Atrial flutter and pacemaker Mode-switch function: In
this case we are interested in checking if the pacemaker with
Mode-switch function can switch from DDD mode to VDI
mode during SVT and switch back after SVT terminates. For
simplicity and clinical relevance, we induce the Atrial flutter
by setting the fast pathway to refractory and activate the node
automata at the circuit entry. This will mimic the behavior
when an early atrial signal successfully gets into the circuit
at the right time and induce Atrial flutter. We terminate atrial
flutter by disabling the slow pathway.
C. Results
1) Maintain heart rate and A-V synchrony: We combined
Case 1 and 2 together and ran the simulation with monitors.
The results are shown in Fig. 16. From the table we can
see that during AV block, general Requirements 3 and 5 are
violated and applying an AAI pacemaker will not help. In this
situation, a DDD pacemaker can satisfy all the requirements
so the therapy is appropriate for a patient with AV-block.
2) Endless Loop Tachycardia: The simulation result is
shown in Fig. 17. We can see from the table that after the
ELT has been induced, varying the heart condition will not
stop it and does not affect the outcome. In fact the pacemaker
“Hijacked” the heart rate and puts the patient into a fixed and
potentially unsafe condition.
3) Atrial flutter and pacemaker Mode-switch function:
The result of the simulation is shown in Fig. 18. We observe
that during Atrial flutter, the close-loop system with a DDD
pacemaker can satisfy Requirement 5 but will violate Re-
quirements 3 and 4. With a VDI pacemaker, Requirements
3 and 4 are satisfied but Requirement 5 is violated. Since
there’s no single mode to satisfy Requirements 3, 4 and
5 during SVT, using VDI mode during Atrial flutter is
more appropriate since Requirements 3 and 4 have higher
Case 3: Endless Loop Tachycardia
Requirements
NSR Bradycardia
No AV block AV block No AV block AV block
1: No v_p during 
refractory
Check Check Check Check
2: Events sensed Check Check Check Check
3: Maintain 
Ventricle rate
Violated Violated Violated Violated
4: Rate increase 
when necessary
Violated Violated Violated Violated
5: A-V synchrony Check Check Check Check
6: No muscle tissue 
conflict
Check Check Check Check
Figure 17. Simulation results for Endless Loop Tachycardia
Case 4: Atrial Flutter and Pacemaker Mode-switch function
Requirements
Atrial Flutter Bradycardia
No PM DDD PM VDI PM No PM DDD PM VDI PM
1: No v_p during 
refractory
N/A Check Check N/A Check Check
2: Events sensed N/A Check Check N/A Check Check
3: Maintain 
Ventricle rate
Check Violated Check Violated Check Check
4: Rate increase 
when necessary
N/A Violated Check N/A Check Check
5: A-V synchrony Violated Check Violated Check Check Violated
6: No muscle 
tissue conflict
Check Check Check Check Check Check
SVT=true &&
State_PM=DDD
N/A Check N/A N/A
SVT=false &&
State_PM=VDI
N/A N/A N/A Check
Figure 18. Simulation results for Atrial flutter and acemaker Mode-switch
priority. During Bradycardia a DDD pacemaker can satisfy
all general requirements thus it’s the appropriate therapy.
From the conditional requirements (last two row in the
table) we observe that the mode-switch function is working
properly. The pacemaker mode-switch function is appropriate
for patient with intermittent SVT. Failure to switch modes
in corresponding heart condition will result in violating the
requirements and cause inappropriate therapy.
VII. DISCUSSION
A. Future Work
As a part of our future efforts we plan to improve
generation of the test vectors that would allow heart rate
smoothening over a desired interval of time. In addition, it
would be beneficial to consider a more complex pacemaker
model which would include Rate Response modes (e.g.,
DDDR mode) specified in [9], [10]. Finally, as an avenue
of the future work we plan to investigate methods for the
closed-loop system verification. With this approach our goal
is to translate the VHM from Simulink into UPPAAL [24],
a widely used tool for system verification, where properties
have to be expressed using temporal logic formulas before
they are checked. Due to the limitations of the monitor
based approach, a migration to UPPAAL presents a natural
way to verify closed-loop system using the timed automata
framework.
B. Conclusion
There is currently no software testing standard for im-
plantable medical devices such as pacemakers and car-
dioverter defibrillators. We present a method for testing of
pacemakers within the closed-loop context of a heart model.
A set of general and patient condition-specific temporal
requirements is specified for the closed-loop system. Based
on these requirements, we presented an interactive and phys-
iologically relevant model-based test generation for basic and
complex pacemaker operations. With the use of monitors, we
demonstrate that the proposed system is capable of testing
common and complex heart conditions across a variety of
pacemaker modes. This system is a step toward a testing
approach for medical cyber-physical systems with the patient-
in-the-loop.
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